Lawrence Salvo
Plus aucun poste en cours
Profil
Lawrence Salvo is the founder of NuGenerex Diagnostics LLC.
Prior to founding NuGenerex Diagnostics LLC, he worked as the Director & Executive VP-Diagnostics at Generex Biotechnology Corp.
He completed his undergraduate degree at St. Vincent De Paul Seminary.
Anciens postes connus de Lawrence Salvo
| Sociétés | Poste | Fin |
|---|---|---|
NuGenerex Diagnostics LLC
 NuGenerex Diagnostics LLC Medical SpecialtiesHealth Technology NuGenerex Diagnostics LLC manufactures and distributes diagnostic testing devices. Its product includes devices for human immunodeficiency virus (HIV), tuberculosis, malaria, and syphilis. The firm also offers Rapid 1-2-3 Hema Dipstick formast tests for hepatis B and C. The company was founded in December 1, 2000 and is headquartered in Miramar, FL. | Directeur Général | 01/03/2017 |
| GENEREX BIOTECHNOLOGY CORPORATION | Directeur/Membre du Conseil | - |
Formation de Lawrence Salvo
| St. Vincent De Paul Seminary | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Generex Biotechnology Corp.
 Generex Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Generex Biotechnology Corp. is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. It builds new kind of healthcare company, which provides support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. The company was founded by Rose C. Perri on September 4, 1997 and is headquartered in Miramar, FL. | Health Technology |
NuGenerex Diagnostics LLC
NuGenerex Diagnostics LLC Medical SpecialtiesHealth Technology NuGenerex Diagnostics LLC manufactures and distributes diagnostic testing devices. Its product includes devices for human immunodeficiency virus (HIV), tuberculosis, malaria, and syphilis. The firm also offers Rapid 1-2-3 Hema Dipstick formast tests for hepatis B and C. The company was founded in December 1, 2000 and is headquartered in Miramar, FL. | Health Technology |
